BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31094090)

  • 1. Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.
    Hsu CC; Hsieh PM; Chen YS; Lo GH; Lin HY; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML; Lin CW
    Cancer Med; 2019 Jul; 8(7):3453-3463. PubMed ID: 31094090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.
    Liu J; Wang K; Yan Z; Xia Y; Li J; Shi L; Zou Q; Wan X; Jiao B; Wang H; Wu M; Zhang Y; Shen F
    PLoS One; 2016; 11(5):e0154767. PubMed ID: 27182739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
    Lin CW; Chen YS; Lin CC; Lee PH; Lo GH; Hsu CC; Hsieh PM; Koh KW; Chou TC; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML
    Clin Transl Gastroenterol; 2018 Jul; 9(6):166. PubMed ID: 29961754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection.
    Perng DS; Hung CM; Lin HY; Morgan P; Hsu YC; Wu TC; Hsieh PM; Yeh JH; Hsiao P; Lee CY; Li YC; Wang YC; Chen YS; Lin CW
    BMC Cancer; 2021 Jul; 21(1):828. PubMed ID: 34273969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
    Lin CW; Chen YS; Lin CC; Lee PH; Lo GH; Hsu CC; Hsieh PM; Koh KW; Bair MJ; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML
    PLoS One; 2018; 13(9):e0202650. PubMed ID: 30180193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
    Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
    J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
    Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
    BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study.
    Zhang Q; Wang Y; Zhang J; Zhang W; Gong J; Ma R
    Technol Cancer Res Treat; 2021; 20():15330338211060180. PubMed ID: 34855560
    [No Abstract]   [Full Text] [Related]  

  • 11. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
    Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
    World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 13. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization.
    Batur T; Argundogan A; Keles U; Mutlu Z; Alotaibi H; Senturk S; Ozturk M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics.
    Holstein E; Binder M; Mikulits W
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.
    Yang Z; Zhuang L; Szatmary P; Wen L; Sun H; Lu Y; Xu Q; Chen X
    Int J Med Sci; 2015; 12(3):256-63. PubMed ID: 25798051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.
    Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y
    Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.